Both in Pharmaceuticals
Ensysce Biosciences vs Exicure
Over the past year ENSC returned −79.7% and XCUR returned −76.3%; their daily moves had a correlation of -0.07.
ENSC −79.7% XCUR −76.3%Growth of $1, one year, split-adjusted
| Metric | ENSC | XCUR |
|---|---|---|
| Price | $0.5183 | $1.12 |
| Market cap | $10.1M | $7.3M |
| Today | −13.31% | 0.00% |
| 1 month | +14.5% | −17.0% |
| 6 months | +3.7% | −70.4% |
| Year to date | −43.7% | −79.3% |
| 1 year | −79.0% | −78.0% |
| Revenue growth (YoY) | −15.1% | — |
| Gross margin | 100.0% | — |
| Net margin | −220.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.2× | — |
| Net cash | $479.9K | $1.7M |
| Dividend yield | — | — |
| Volatility (60d) | 137.6% | 82.2% |
| Short % of float | 7.5% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).